Expert Opinion on Therapeutic Targets
Overview
Expert Opinion on Therapeutic Targets is a peer-reviewed journal that provides insightful analysis and expert opinions on the latest advancements in therapeutic targets for various diseases and conditions. It covers a wide range of topics, including novel drug targets, emerging therapies, and personalized medicine, making it an essential resource for researchers, clinicians, and pharmaceutical professionals seeking to stay updated on cutting-edge therapeutic strategies.
Details
Details
Abbr.
Expert Opin Ther Targets
Publisher
Informa Healthcare
Start
2001
End
Continuing
Frequency
Twelve no. a year
p-ISSN
1472-8222
e-ISSN
1744-7631
Country
United Kingdom
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 2815
106
SJR / Ranks: 2139
1423
CiteScore / Ranks: 1464
9.90
JIF / Ranks: 1190
5.8
Recent Articles
1.
Das S, Fisher P
Expert Opin Ther Targets
. 2025 Mar;
:1-18.
PMID: 40056146
Introduction: Metastasis is a principal cause of patient morbidity and death from solid cancers with current therapies being inadequate. Areas Covered: Detailed genomic analyses document mutational differences between the initial...
2.
Tomos I, Kanellopoulou P, Nastos D, Aidinis V
Expert Opin Ther Targets
. 2025 Feb;
29(1-2):43-57.
PMID: 39985559
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease with a dismal prognosis. While the standard-of-care (SOC) drugs approved for IPF represent a significant advancement in antifibrotic...
3.
Rismani E, Hossein-Khannazer N, Hassan M, Shams E, Najimi M, Vosough M
Expert Opin Ther Targets
. 2025 Feb;
29(1-2):59-73.
PMID: 39985417
Introduction: Tumor cell's resistance, high recurrence rate, and low overall survival rate have made hepatocellular carcinoma (HCC) a major health concern. The combination of advanced targeted therapies such as immunotherapy,...
4.
Liu G, Tiotiu A, Hansbro P
Expert Opin Ther Targets
. 2025 Feb;
29(1-2):9-12.
PMID: 39981912
No abstract available.
5.
Poole C, Allen I
Expert Opin Ther Targets
. 2025 Feb;
29(1-2):13-16.
PMID: 39918377
No abstract available.
6.
Sangotra A, Lieberman A
Expert Opin Ther Targets
. 2025 Feb;
29(1-2):29-41.
PMID: 39915972
Introduction: Spinal and Bulbar Muscular Atrophy (SBMA) is a slowly progressive, X-linked, and sex-limited degenerative disorder affecting lower motor neurons and skeletal muscle which lacks disease-modifying therapies. This disease is...
7.
8.
Abad-Yang N, Raguseo F, Di Michele L, Patani R, Di Antonio M
Expert Opin Ther Targets
. 2025 Feb;
29(1-2):1-4.
PMID: 39902643
No abstract available.
9.
Xin X, Koenen R
Expert Opin Ther Targets
. 2025 Jan;
29(1-2):17-28.
PMID: 39817690
Introduction: Cardiovascular disease (CVD) is the leading cause of death worldwide. Platelet-derived extracellular vesicles (PEV) have attracted extensive attention in cardiovascular disease research in recent years because their cargo is...
10.
Gowtham A, Chauhan C, Rahi V, Kaundal R
Expert Opin Ther Targets
. 2024 Dec;
28(12):1149-1175.
PMID: 39710973
Introduction: Ischemic stroke (IS), a major cause of mortality and disability worldwide, remains a significant healthcare challenge due to limited therapeutic options. Ferroptosis, a distinct iron-dependent form of regulated cell...